Pipeline

JIN-A04

Introduction of JIN-A04

  • Oral tyrosine kinase inhibitor targeting HER2 and EGFR exon 20 insertion mutations in NSCLC.

JIN-A04 Conference Presentation Status

Conference Topic
2025 AACR (Poster presentation) Preclinical
2023 WCLC (Poster presentation) Preclinical
2023 AACR (Poster presentation) Preclinical
  • AACR: American Association for Cancer Research
  • WCLC: World Conference on Lung Cancer

National Research and Development Project

  • Selection as a project in the 1st phase of the 2025 National New Drug Development Program funded by KDDF